AstraZeneca Pharma shares gain 3% on CDSCO nod for expanded use of cancer drug Imfinzi

Shares of AstraZeneca Pharma India gained as much as 3 percent to Rs 6,890 in afternoon trade on March 3 after the company announced it has secured regulatory approval to expand the use of its cancer therapy, Imfinzi, in the country.

The Central Drugs Standard Control Organisation (CDSCO) has granted the company permission to import, sell, and distribute Durvalumab (Imfinzi) for an additional indication—treating patients with unresectable hepatocellular carcinoma (uHCC), a form of liver cancer.

This approval allows the use of Durvalumab in combination with Tremelimumab, broadening treatment options for patients battling advanced-stage liver cancer. While the company still requires other statutory approvals before launching the expanded indication in India, the regulatory green light marks a crucial step in AstraZeneca Pharma’s oncology portfolio expansion.

AstraZeneca Pharma India delivered a stellar performance in Q3FY25, with net profit surging 94.9 percent year-on-year to Rs 30.8 crore, up from Rs 15.8 crore in the same period last year.

Related Posts

  • Pharma
  • June 18, 2025
  • 91 views
Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

Glenmark Pharmaceuticals said that the United States’ Food and Drug Administration (FDA) has concluded inspection of its manufacturing facility in Monroe, North Carolina. Glenmark Pharmaceuticals said that the United States’…

  • Pharma
  • June 18, 2025
  • 79 views
ED conducts searches across six States in drug trafficking case

The Enforcement Directorate on Tuesday conducted searches at 15 locations, including the premises of five pharmaceutical companies, across six States in connection with a drug trafficking case registered in Punjab.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

ED conducts searches across six States in drug trafficking case

ED conducts searches across six States in drug trafficking case

Gurugram: Teen dies after ‘friendly’ blow to chest; hospital role under scanner

Gurugram: Teen dies after ‘friendly’ blow to chest; hospital role under scanner

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Zydus Healthcare appoints Swati Dalal MD

Zydus Healthcare appoints Swati Dalal MD

Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda